Liquidia (LQDA) Enterprise Value (2020 - 2026)
Liquidia (LQDA) posted quarterly Enterprise Value of -$222.8 million for Q1 2026, down 31.24% year-over-year from -$324.0 million in Q1 2025, and down 16.84% quarter-over-quarter from -$190.7 million in Q4 2025.
Liquidia (LQDA) Enterprise Value (2020 - 2026) Analysis & Trends
Liquidia's Enterprise Value history runs 7 years deep, the most recent figure standing at -$222.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 31.24% year-over-year to -$222.8 million; the TTM figure through Mar 2026 stood at -$222.8 million (down 31.24% YoY), while the FY2025 annual figure was -$190.7 million, down 8.05% from the prior year.
- Enterprise Value for Q1 2026 stood at -$222.8 million, down from -$190.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$57.8 million in Q1 2022, with the low at -$222.8 million in Q1 2026.
- The 5-year median for Enterprise Value is -$133.1 million (2024), against an average of -$134.2 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value sank 168.11% in 2024, then rose 22.94% in 2025.
- Liquidia's Enterprise Value stood at -$93.3 million in 2022, then advanced by 10.3% to -$83.7 million in 2023, then tumbled by 110.9% to -$176.5 million in 2024, then fell by 8.05% to -$190.7 million in 2025, then decreased by 16.84% to -$222.8 million in 2026.
- Business Quant data shows LQDA's Enterprise Value at -$222.8 million in Q1 2026, -$190.7 million in Q4 2025, and -$157.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Liquidia | 6.31 Bn | 6.03 Bn | 160.92 Mn | -284.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -284.18 Mn |
| Mar 31, 2026 | -222.79 Mn |
| Dec 31, 2025 | -190.68 Mn |
| Sep 30, 2025 | -157.50 Mn |
| Jun 30, 2025 | -173.42 Mn |
| Mar 31, 2025 | -169.76 Mn |
| Dec 31, 2024 | -176.48 Mn |
| Sep 30, 2024 | -204.37 Mn |
| Jun 30, 2024 | -133.09 Mn |
| Mar 31, 2024 | -157.86 Mn |
| Dec 31, 2023 | -83.68 Mn |
| Sep 30, 2023 | -76.23 Mn |
| Jun 30, 2023 | -88.20 Mn |
| Mar 31, 2023 | -94.41 Mn |
| Dec 31, 2022 | -93.28 Mn |
| Sep 30, 2022 | -98.32 Mn |
| Jun 30, 2022 | -103.84 Mn |
| Mar 31, 2022 | -57.80 Mn |
| Dec 31, 2021 | -57.49 Mn |
| Sep 30, 2021 | -64.10 Mn |